Bora CDMO Bora CDMO

X

CAS 54197-66-9 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 54197-66-9
Also known as: 54197-66-9, 6-hydroxy-3,4-dihydroquinolin-2(1h)-one, 6-hydroxy-3,4-dihydro-1h-quinolin-2-one, 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline, 6-hydroxy-2(1h)-3,4-dihydroquinolinone, 3,4-dihydro-6-hydroxy-2(1h)-quinolinone
Molecular Formula
C9H9NO2
Molecular Weight
163.17  g/mol
InChI Key
HOSGXJWQVBHGLT-UHFFFAOYSA-N
FDA UNII
2C5NDT39OC

1 2D Structure

CAS 54197-66-9

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-hydroxy-3,4-dihydro-1H-quinolin-2-one
2.1.2 InChI
InChI=1S/C9H9NO2/c11-7-2-3-8-6(5-7)1-4-9(12)10-8/h2-3,5,11H,1,4H2,(H,10,12)
2.1.3 InChI Key
HOSGXJWQVBHGLT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC(=O)NC2=C1C=C(C=C2)O
2.2 Other Identifiers
2.2.1 UNII
2C5NDT39OC
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 54197-66-9

2. 6-hydroxy-3,4-dihydroquinolin-2(1h)-one

3. 6-hydroxy-3,4-dihydro-1h-quinolin-2-one

4. 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline

5. 6-hydroxy-2(1h)-3,4-dihydroquinolinone

6. 3,4-dihydro-6-hydroxy-2(1h)-quinolinone

7. 6-hydroxy-3,4-dihydrocarbostyril

8. 2(1h)-quinolinone, 3,4-dihydro-6-hydroxy-

9. Cilostazol Related Compound A

10. 6-hydroxy-3,4-dihydro-1h-quinoline-2-one

11. 3,4-dihydro-6-hydroxycarbostyril

12. 6-hydroxy-3,4-dihydroquinolinone

13. 6-hydroxy-1,2,3,4-tetrahydro-2-quinolinone

14. 2c5ndt39oc

15. 2-oxo-1,2,3,4-tetrahydroquinolin-6-ol

16. Chembl2430710

17. Mfcd02179410

18. 6-hydroxy-3,4-dihydro-1h Quinolin-2-one

19. 6-hydroxyl-3.4-dihydrocarbostyril

20. Unii-2c5ndt39oc

21. 6-hydroxyl

22. Cilostazol Related Compound A [usp]

23. 6-hydroxy-1,3,4-trihydroquinolin-2-one

24. Ec 611-111-4

25. Schembl426336

26. 3,4-dihydro-2,6-quinolinediol

27. Dtxsid60202548

28. 6-hydroxyl-3,4-dihydrocarbostyril

29. 6-hydroxy-3,4-dihydro-carbostyril

30. Bcp22789

31. Zinc3957998

32. 3,4-dihydro-6-hydroxy-carbostyril;

33. 6-hydroxy-3, 4-dihydro-carbostyril

34. Ac-498

35. Bdbm50493468

36. 6-hydroxy-3,4-dihydro-2-quinolinone

37. Akos008090878

38. Bcp9000194

39. Cs-w002905

40. Fs-1287

41. 6-hydroxyl-3,4-dihydroquinoline-2-one

42. 6-hydroxy-3,4dihydroquinolin-2(1h)-one

43. Bp-10200

44. Sy002022

45. 34-dihydro-6-hydroxy-2(1h)-quinolinone

46. 3,4-dihydro-6-hydroxyquinolin-2(1h)-one

47. 6-hydroxy-3,4-dihydro-2-(1h)-quinolone

48. Db-002613

49. 3,4-dihydro-6-hydroxy-2-(1h)-quinolinone

50. 6-hydroxy-3,4-dihydro-2(1 H)-quinolinone

51. Am20061119

52. D3448

53. Ft-0640226

54. 6-hydroxy-1,2,3,4-tetrahydroquinolin-2-one

55. En300-27032

56. 6-hydroxy-3,4-dihydro-(1h)-quinoline-2-one

57. Cilostazol Related Compound A [usp-rs]

58. 6-hydroxy-2-oxo-1,2,3,4-tetrahydro Quinoline

59. 197h669

60. 6-hydroxy-3,4-dihydro-2(1h)-quinolinone, 97%

61. 3,4-dihydro-6-hydroxycarbostyril-2(1h)quinolinone

62. Cilostazol Related Compound A [usp Impurity]

63. J-518785

64. Q27254550

65. Cilostazol Related Compound A, United States Pharmacopeia (usp) Reference Standard

66. 6-hydroxy-3,4-dihydroquinolin-2(1h)-one;3,4-dihydro-6-hydroxycarbostyril-2(1h)quinolinone; 6-hydroxy-3,4-dihydro-2(1h)-quinolinone

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 163.17 g/mol
Molecular Formula C9H9NO2
XLogP30.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass163.063328530 g/mol
Monoisotopic Mass163.063328530 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count12
Formal Charge0
Complexity193
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
73963-42-5
Cilostazol
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Co...
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
73963-42-5
Cilostazol
LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients an...
LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate chemicals for generic pharmaceutical companies. Our Development Team focus strategically on the core therapeutic areas: cardiovascular, anti-depressant, allergic, healthcare and plant extraction. We provide technical support and efficient regulatory documentation for manufacturers, intellectual property(IP) was always carefully considered as well. We also provide excellent outsourcing services to customers and laboratory support.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
73963-42-5
Cilostazol
Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shangha...
Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shanghai is only 1.5 hours by car. Established in 2006, we have developed quickly into a comprehensive entity engaged in and marketing, developing and manufacturing of Active Pharmaceutical Ingredients, intermediates and fine chemicals.Our collaboration production site is in the national chemical park in our city: Nantong Rudong Yangkou Chemical park. Available test instrument in the production site: IR, UV, HPLC, GC, etc.. Production equipment: More than 50 reactors, size from 1L to 3000L , reaction temperature from -10℃ to +300℃.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY